Progression to end-stage renal disease is reduced with eculizumab in patients with atypical haemolytic uraemic syndrome

Detalles Bibliográficos
Autores principales: Walle, J Vande, Johnson, S, Harvey, E, Kincaid, J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Poster Presentation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4472974/
http://dx.doi.org/10.1186/cc14409
_version_ 1782377158148096000
author Walle, J Vande
Johnson, S
Harvey, E
Kincaid, J
author_facet Walle, J Vande
Johnson, S
Harvey, E
Kincaid, J
author_sort Walle, J Vande
collection PubMed
description
format Online
Article
Text
id pubmed-4472974
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-44729742015-06-25 Progression to end-stage renal disease is reduced with eculizumab in patients with atypical haemolytic uraemic syndrome Walle, J Vande Johnson, S Harvey, E Kincaid, J Crit Care Poster Presentation BioMed Central 2015 2015-03-16 /pmc/articles/PMC4472974/ http://dx.doi.org/10.1186/cc14409 Text en Copyright © 2015 Walle et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Poster Presentation
Walle, J Vande
Johnson, S
Harvey, E
Kincaid, J
Progression to end-stage renal disease is reduced with eculizumab in patients with atypical haemolytic uraemic syndrome
title Progression to end-stage renal disease is reduced with eculizumab in patients with atypical haemolytic uraemic syndrome
title_full Progression to end-stage renal disease is reduced with eculizumab in patients with atypical haemolytic uraemic syndrome
title_fullStr Progression to end-stage renal disease is reduced with eculizumab in patients with atypical haemolytic uraemic syndrome
title_full_unstemmed Progression to end-stage renal disease is reduced with eculizumab in patients with atypical haemolytic uraemic syndrome
title_short Progression to end-stage renal disease is reduced with eculizumab in patients with atypical haemolytic uraemic syndrome
title_sort progression to end-stage renal disease is reduced with eculizumab in patients with atypical haemolytic uraemic syndrome
topic Poster Presentation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4472974/
http://dx.doi.org/10.1186/cc14409
work_keys_str_mv AT wallejvande progressiontoendstagerenaldiseaseisreducedwitheculizumabinpatientswithatypicalhaemolyticuraemicsyndrome
AT johnsons progressiontoendstagerenaldiseaseisreducedwitheculizumabinpatientswithatypicalhaemolyticuraemicsyndrome
AT harveye progressiontoendstagerenaldiseaseisreducedwitheculizumabinpatientswithatypicalhaemolyticuraemicsyndrome
AT kincaidj progressiontoendstagerenaldiseaseisreducedwitheculizumabinpatientswithatypicalhaemolyticuraemicsyndrome

Ejemplares similares